Return to program book search
Photodynamic Therapy in Difficult and High-Risk Patient Populations
Saturday, March 02
1:00 PM - 3:00 PM
Edward V. Maytin, MD, PhD, FAAD - Handout
- Angela O. Kyei, MD, FAAD
- Fernanda H. Sakamoto, MD - Handout
- Alexandra Y. Zhang, MD, FAAD
Following this course, the attendee should be able to:
- Identify patient populations with few other treatment options who might benefit from photodynamic therapy (PDT).
- Acquire the latest information on field treatment approaches for organ transplant patients, combining PDT with other modalities for prevention and treatment of skin cancer
- Recognize and try to minimize the side effects of PDT in patients with skin types IV-VI.
Photodynamic therapy (PDT) is now widely recognized as an effective, non-surgical treatment modality for actinic keratoses (AK) and non-melanoma skin cancers. However, a newer niche for PDT is developing for certain populations of patients who have few other treatment options. In this forum, data will be presented on the use of PDT in the organ transplant population for treatment and prevention of skin tumors. Prospects for new combination PDT approaches in transplant patients and other high-risk groups will be described. Finally, PDT for refractory dermatoses, and its use in skin of color (skin types IV to VI), will be discussed.
|Saturday, March 02|
|1:00 PM||Basic and combination approaches to PDT for difficult conditions / Dr. Maytin|
|1:25 PM||PDT for inflammatory conditions and skin of color / Dr. Kyei|
|1:50 PM||New PDT approaches for acne / Dr. Sakamoto|
|2:15 PM||Field approaches for NMSC in the transplant population / Dr. Zhang|
|2:40 PM||Panel discussion: PDT in the management of difficult patients / All faculty|